April 01, 2026

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

Conexiant

April 01, 2026

Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer

A novel KRAS G12D inhibitor produced disease control in almost 80% of patients with heavily pretreated advanced or metastatic KRAS G12D–mutated pancreatic cancer in an early-phase study reported at th...

The ASCO Post

April 01, 2026

Your Biological Age? It's in the Blood

Multi-marker model may refine risk prediction and preventive testing

The Pathologist

April 01, 2026

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Conexiant

March 31, 2026

How FIU and Baptist Health are Using AI and Sound to Detect Heart Disease Earlier

Researchers at Florida International University (FIU), working in collaboration with Baptist Health South Florida, are combining a digital stethoscope with artificial intelligence (AI) and advanced sound analysis to better detect subtle signs of heart disease long before symptoms appear.

Baptist Health South Florida

March 31, 2026

AHA Updates Heart-Healthy Dietary Guidance

Nine evidence-based features now frame cardiovascular risk reduction across the life course, with sharper language on alcohol, ultraprocessed foods, and plant protein

Conexiant

March 30, 2026

Can This Device Help Neurosurgeons Better Treat Normal Pressure Hydrocephalus — and More?

A Keck Medicine of USC neurointerventionalist discusses how a minimally invasive, endovascularly implantable cerebrospinal fluid shunt is the next-generation treatment for normal pressure hydrocephalus — and possibly more.

Keck Medicine of USC

March 30, 2026

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Explore the latest advancements in diagnosing and treating neuroendocrine tumors as discussed by Paula S. Kennedy-Newton at JADPRO Live 2025.

JADPRO

March 30, 2026

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies

Explore the latest advances in metastatic melanoma treatment from leading experts at Mass General Hospital.

JADPRO

March 30, 2026

Root Canal Treatment Linked to Metabolic Improvements

Longitudinal NMR metabolomics study suggests clearing apical periodontitis may reduce systemic inflammation and improve glucose and lipid profiles

The Analytical Scientist